171. ウィルソン病 Disease details / Clinical trials / Drug dev / DR info

24 hour copper IN urine and liver function test
   Assiut University
      2024   -   NCT05792319   -
64cucl2
   Aarhus University Hospital
      2021   Phase 2   EUCTR2021-000102-25-DK   Denmark
   The Department of Hepatology and Gastroenterology, Aarhus University Hospital
      2019   Phase 4   EUCTR2019-000905-57-DK   Denmark
900MG teta 4HCL once daily formulation
   Orphalan
      2024   Phase 1   NCT06128954   United Kingdom
Adeno-associated viral vector serotype 3B encoding shortened human ATP7B
   Vivet Therapeutics SAS
      2021   Phase 1;Phase 2   EUCTR2020-000963-22-DK   Denmark;Germany;United Kingdom;United States
      2021   Phase 1;Phase 2   EUCTR2020-000963-22-DE   Denmark;Germany;United Kingdom;United States
Adeno-associated viral vector serotype 9 encoding human ATP7B
   Ultragenyx Pharmaceutical Inc.
      2023   Phase 1;Phase 2;Phase 3   EUCTR2020-005266-34-PT   Argentina;Austria;Brazil;Canada;France;Germany;Italy;Japan;Poland;Portugal;Spain;United Kingdom;United States
      2022   Phase 1;Phase 2;Phase 3   EUCTR2020-005266-34-ES   Argentina;Austria;Brazil;Canada;France;Germany;Italy;Japan;Poland;Portugal;Spain;United Kingdom;United States
Allogeneic mesenchymal stem cell transplantation
   Murat Kantarcioglu
      2011   -   NCT01378182   Turkey
ALXN1840
   Aarhus University Hospital
      2021   Phase 2   EUCTR2021-000102-25-DK   Denmark
   Alexion
      2023   -   NCT05686564   -
   Alexion Pharmaceuticals
      2020   Phase 1   NCT04526210   United States
      2020   Phase 1   NCT04526197   United States
      2014   Phase 2   NCT02273596   Austria;Germany;Poland;United Kingdom;United States
   Alexion Pharmaceuticals Inc.
      2021   Phase 2   EUCTR2020-005832-31-DK   Denmark
   Alexion Pharmaceuticals, Inc
      2021   Phase 2   EUCTR2019-003711-60-DE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Korea, Republic of;New Zealand;Poland;Russian Federation;Serbia;Singapore;Spain;Sweden;Turkey;United Kingdom;United States
      2020   Phase 2   EUCTR2019-003711-60-GB   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Korea, Republic of;New Zealand;Poland;Russian Federation;Serbia;Singapore;Spain;Sweden;Turkey;United Kingdom;United States
      2020   Phase 2   EUCTR2019-003711-60-FR   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Korea, Republic of;New Zealand;Poland;Russian Federation;Serbia;Singapore;Spain;Sweden;Turkey;United Kingdom;United States
      2020   Phase 2   EUCTR2019-003711-60-DK   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Korea, Republic of;New Zealand;Poland;Russian Federation;Serbia;Singapore;Spain;Sweden;Turkey;United Kingdom;United States
      2020   Phase 2   EUCTR2019-003711-60-AT   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Korea, Republic of;New Zealand;Poland;Russian Federation;Serbia;Singapore;Spain;Sweden;Turkey;United Kingdom;United States
      2020   Phase 3   EUCTR2017-004135-36-PT   Australia;Austria;Belgium;Brazil;Canada;Colombia;Czech Republic;Denmark;France;Germany;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
      2020   Phase 3   EUCTR2017-004135-36-NL   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
      2019   Phase 3   EUCTR2017-004135-36-SE   Australia;Austria;Belgium;Brazil;Canada;Colombia;Czech Republic;Denmark;France;Germany;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
      2019   Phase 3   EUCTR2017-004135-36-DK   Australia;Austria;Belgium;Brazil;Canada;Colombia;Czech Republic;Czechia;Denmark;France;Germany;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004135-36-DE   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czechia;Denmark;France;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Democratic People's Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004135-36-CZ   Australia;Austria;Belgium;Brazil;Canada;Colombia;Czech Republic;Czechia;Denmark;France;Germany;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004135-36-AT   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Democratic People's Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
      -   Phase 3   EUCTR2017-004135-36-PL   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
      -   Phase 3   EUCTR2017-004135-36-BE   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
   Alexion Pharmaceuticals, Inc.
      2021   Phase 3   NCT05047523   Australia;France;Germany;Japan;Korea, Republic of;Poland;Spain;United Kingdom
      2021   Phase 3   EUCTR2021-001015-82-ES   Australia;Austria;Canada;Czechia;Denmark;France;Germany;Hungary;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;Turkey;United Kingdom;United States
      2021   Phase 3   EUCTR2021-001015-82-DE   Australia;France;Germany;Japan;Korea, Republic of;Poland;Spain;United Kingdom
      2020   Phase 2   NCT04573309   New Zealand;United Kingdom;United States
      2020   Phase 2   EUCTR2020-001104-41-GB   United Kingdom
      2019   Phase 1   NCT05641311   United Kingdom
      2018   Phase 3   NCT03403205   Australia;Austria;Belgium;Canada;Czechia;Denmark;France;Germany;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;New Zealand;Poland;Russian Federation;Serbia;Singapore;Spain;Taiwan;Turkey;United Kingdom;United States
      -   Phase 3   EUCTR2021-001015-82-PL   Australia;Austria;Canada;Czechia;Denmark;France;Germany;Hungary;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;Turkey;United Kingdom;United States
Artamin 150 MG
   Orphalan
      2019   Phase 3   EUCTR2016-003876-29-BE   Austria;Belgium;Brazil;Denmark;France;Germany;Italy;Poland;Sweden;United Kingdom;United States
Artamin 250 MG
   Orphalan
      2019   Phase 3   EUCTR2016-003876-29-BE   Austria;Belgium;Brazil;Denmark;France;Germany;Italy;Poland;Sweden;United Kingdom;United States
BIS-choline tetrathiomolybdate
   Aarhus University Hospital
      2021   Phase 2   EUCTR2021-000102-25-DK   Denmark
   Alexion Pharmaceuticals Inc.
      2021   Phase 2   EUCTR2020-005832-31-DK   Denmark
   Alexion Pharmaceuticals, INC.
      2014   Phase 2   EUCTR2014-001703-41-DE   Austria;Germany;Poland;United Kingdom;United States
   Alexion Pharmaceuticals, Inc
      2021   Phase 2   EUCTR2019-003711-60-DE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Korea, Republic of;New Zealand;Poland;Russian Federation;Serbia;Singapore;Spain;Sweden;Turkey;United Kingdom;United States
      2020   Phase 2   EUCTR2019-003711-60-GB   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Korea, Republic of;New Zealand;Poland;Russian Federation;Serbia;Singapore;Spain;Sweden;Turkey;United Kingdom;United States
      2020   Phase 2   EUCTR2019-003711-60-FR   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Korea, Republic of;New Zealand;Poland;Russian Federation;Serbia;Singapore;Spain;Sweden;Turkey;United Kingdom;United States
      2020   Phase 2   EUCTR2019-003711-60-DK   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Korea, Republic of;New Zealand;Poland;Russian Federation;Serbia;Singapore;Spain;Sweden;Turkey;United Kingdom;United States
      2020   Phase 2   EUCTR2019-003711-60-AT   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Korea, Republic of;New Zealand;Poland;Russian Federation;Serbia;Singapore;Spain;Sweden;Turkey;United Kingdom;United States
      2020   Phase 3   EUCTR2017-004135-36-PT   Australia;Austria;Belgium;Brazil;Canada;Colombia;Czech Republic;Denmark;France;Germany;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
      2020   Phase 3   EUCTR2017-004135-36-NL   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
      2019   Phase 3   EUCTR2017-004135-36-SE   Australia;Austria;Belgium;Brazil;Canada;Colombia;Czech Republic;Denmark;France;Germany;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
      2019   Phase 3   EUCTR2017-004135-36-DK   Australia;Austria;Belgium;Brazil;Canada;Colombia;Czech Republic;Czechia;Denmark;France;Germany;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004135-36-DE   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czechia;Denmark;France;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Democratic People's Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004135-36-CZ   Australia;Austria;Belgium;Brazil;Canada;Colombia;Czech Republic;Czechia;Denmark;France;Germany;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004135-36-AT   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Democratic People's Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
      -   Phase 3   EUCTR2017-004135-36-PL   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
      -   Phase 3   EUCTR2017-004135-36-BE   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
   Alexion Pharmaceuticals, Inc.
      2020   Phase 2   NCT04422431   Australia;Austria;Belgium;Canada;Denmark;Germany;Korea, Republic of;New Zealand;Poland;Russian Federation;Singapore;Spain;United Kingdom;United States
      2020   Phase 2   EUCTR2020-001104-41-GB   United Kingdom
      2014   Phase 2   EUCTR2014-001703-41-AT   Austria;Germany;Poland;United Kingdom;United States
   Wilson Therapeutics AB
      2018   Phase 3   EUCTR2017-004135-36-HU   Austria;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004135-36-GB   Austria;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004135-36-FR   Austria;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004135-36-ES   Austria;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Spain;United Kingdom;United States
      2015   Phase 2   EUCTR2014-001703-41-GB   Austria;Germany;Poland;United Kingdom;United States
      2014   Phase 2   EUCTR2014-001703-41-PL   Austria;Germany;Poland;United Kingdom;United States
BIS-choline tetrathiomolybdate, BIS[(2-hydroxyethyl)trimethylammonium] tetrathiomolybdate
   Alexion Pharmaceuticals, Inc.
      2021   Phase 3   EUCTR2021-001015-82-ES   Australia;Austria;Canada;Czechia;Denmark;France;Germany;Hungary;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;Turkey;United Kingdom;United States
      2021   Phase 3   EUCTR2021-001015-82-DE   Australia;France;Germany;Japan;Korea, Republic of;Poland;Spain;United Kingdom
      -   Phase 3   EUCTR2021-001015-82-PL   Australia;Austria;Canada;Czechia;Denmark;France;Germany;Hungary;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;Turkey;United Kingdom;United States
Botulinum toxin type A
   The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine
      2016   -   NCT06762509   China
Bupropion hydrochloride
   Alexion Pharmaceuticals
      2020   Phase 1   NCT04526210   United States
Celecoxib
   Alexion Pharmaceuticals
      2020   Phase 1   NCT04526197   United States
Copper
   Anhui Provincial Hospital
      2017   -   ChiCTR-DDD-17010552   China
   First Affiliated Hospital of Sun Yat-Sen University
      2020   -   ChiCTR2200057544   China
   Shanghai Tongren Hospital
      2019   Phase 0   ChiCTR1900023410   China
   The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine
      2023   Phase 1   ChiCTR2500098794   China
Copper (64CU) chloride
   Aarhus University Hospital
      2021   Phase 2   EUCTR2021-000102-25-DK   Denmark
   The Department of Hepatology and Gastroenterology, Aarhus University Hospital
      2019   Phase 4   EUCTR2019-000905-57-DK   Denmark
Cufence
   Univar Solutions, B.V.
      2021   Phase 4   EUCTR2020-004604-33-PL   Denmark;France;Germany;Poland
      2021   Phase 4   EUCTR2020-004604-33-FR   Denmark;France;Germany;Poland
      2021   Phase 4   EUCTR2020-004604-33-DK   Denmark;France;Germany;Poland
      2021   Phase 4   EUCTR2020-004604-33-DE   Denmark;France;Germany;Poland
Cuprior
   Orphalan
      2024   Phase 1   NCT06128954   United Kingdom
Cuprior 150 MG
   Alexion Pharmaceuticals Inc.
      2021   Phase 2   EUCTR2020-005832-31-DK   Denmark
Cuprior 150 MG FILM-coated tablets
   Orphalan
      2019   Phase 3   EUCTR2016-003876-29-BE   Austria;Belgium;Brazil;Denmark;France;Germany;Italy;Poland;Sweden;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003876-29-DK   Austria;Belgium;Brazil;Denmark;France;Germany;Italy;Poland;Sweden;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003876-29-DE   Austria;Belgium;Brazil;Denmark;France;Germany;Italy;Poland;Sweden;United Kingdom;United States
Cuprior 150MG FILM-coated tablets
   gmp-orphan SA
      2017   Phase 3   EUCTR2016-003876-29-GB   Austria;Belgium;Brazil;Denmark;France;Germany;Italy;Poland;Sweden;United Kingdom;United States
D-penicillamine
   GMP ORPHAN SA
      2017   Phase 3   EUCTR2016-003876-29-IT   Austria;Brazil;Denmark;France;Germany;Italy;Micronesia, Federated States of;Poland;United Kingdom;United States
   gmp-orphan SA
      2017   Phase 3   EUCTR2016-003876-29-GB   Austria;Belgium;Brazil;Denmark;France;Germany;Italy;Poland;Sweden;United Kingdom;United States
D-penicillamine 150MG
   Orphalan
      2019   Phase 3   EUCTR2016-003876-29-BE   Austria;Belgium;Brazil;Denmark;France;Germany;Italy;Poland;Sweden;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003876-29-DK   Austria;Belgium;Brazil;Denmark;France;Germany;Italy;Poland;Sweden;United Kingdom;United States
D-penicillamine 250 MG
   Orphalan
      2019   Phase 3   EUCTR2016-003876-29-BE   Austria;Belgium;Brazil;Denmark;France;Germany;Italy;Poland;Sweden;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003876-29-DK   Austria;Belgium;Brazil;Denmark;France;Germany;Italy;Poland;Sweden;United Kingdom;United States
Dexmedetomidine
   The First Affiliated Hospital of Anhui University of Chinese Medicine
      2021   Phase 0   ChiCTR2100050549   China
Dmps
   Second Affiliated Hospital, School of Medicine, Zhejiang University
      2019   Early Phase 1   NCT03957720   China
Dmsa
   Second Affiliated Hospital, School of Medicine, Zhejiang University
      2019   Early Phase 1   NCT03957720   China
Fibroscan
   University of Aarhus
      2016   -   NCT02702765   Denmark
Functional hepatic nitrogen clearance
   University of Aarhus
      2016   -   NCT02702765   Denmark
Galactose
   University of Aarhus
      2016   -   NCT02702765   Denmark
Gandouling
   Jun Li
      2023   Phase 4   NCT05305872   China
   The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine
      2023   Phase 1   ChiCTR2500098794   China
      2021   Phase 0   ChiCTR2100053629   China
Imaging and fluid biomarkers
   University College, London
      2018   -   NCT04212195   United Kingdom
Intravenous LY-M003
   Chaohui Yu
      2024   Early Phase 1   NCT06650319   China
Liver biopsy
   University of Aarhus
      2016   -   NCT02702765   Denmark
LOW copper diet
   Second Affiliated Hospital, School of Medicine, Zhejiang University
      2004   -   NCT04965545   China
Metalcaptase
   Alexion Pharmaceuticals Inc.
      2021   Phase 2   EUCTR2020-005832-31-DK   Denmark
Metalcaptase® 150 MG gastro-resistant tablet
   Orphalan
      2017   Phase 3   EUCTR2016-003876-29-DE   Austria;Belgium;Brazil;Denmark;France;Germany;Italy;Poland;Sweden;United Kingdom;United States
Metalcaptase® 300 MG gastro-resistant tablet
   Orphalan
      2017   Phase 3   EUCTR2016-003876-29-DE   Austria;Belgium;Brazil;Denmark;France;Germany;Italy;Poland;Sweden;United Kingdom;United States
MWAV201
   Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
      2024   -   NCT06663878   China
Next generation sequencing
   University College, London
      2018   -   NCT04212195   United Kingdom
NPC-02
   Nobelpharma
      2005   Phase 3   NCT00212355   -
Once A DAY trientine
   Yale University
      2010   -   NCT01472874   United States
Pemine - 150 MG capsule rigide 50 capsule
   GMP ORPHAN SA
      2017   Phase 3   EUCTR2016-003876-29-IT   Austria;Brazil;Denmark;France;Germany;Italy;Micronesia, Federated States of;Poland;United Kingdom;United States
Penicillamine
   Alexion Pharmaceuticals Inc.
      2021   Phase 2   EUCTR2020-005832-31-DK   Denmark
   Alexion Pharmaceuticals, Inc
      2020   Phase 3   EUCTR2017-004135-36-PT   Australia;Austria;Belgium;Brazil;Canada;Colombia;Czech Republic;Denmark;France;Germany;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
      2020   Phase 3   EUCTR2017-004135-36-NL   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
      2019   Phase 3   EUCTR2017-004135-36-SE   Australia;Austria;Belgium;Brazil;Canada;Colombia;Czech Republic;Denmark;France;Germany;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
      2019   Phase 3   EUCTR2017-004135-36-DK   Australia;Austria;Belgium;Brazil;Canada;Colombia;Czech Republic;Czechia;Denmark;France;Germany;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004135-36-DE   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czechia;Denmark;France;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Democratic People's Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004135-36-CZ   Australia;Austria;Belgium;Brazil;Canada;Colombia;Czech Republic;Czechia;Denmark;France;Germany;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004135-36-AT   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Democratic People's Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
      -   Phase 3   EUCTR2017-004135-36-PL   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
      -   Phase 3   EUCTR2017-004135-36-BE   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
   Orphalan
      2018   Phase 3   NCT03539952   Belgium;Brazil;Denmark;France;Germany;Italy;Poland;Sweden;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003876-29-DE   Austria;Belgium;Brazil;Denmark;France;Germany;Italy;Poland;Sweden;United Kingdom;United States
   Second Affiliated Hospital, School of Medicine, Zhejiang University
      2019   Early Phase 1   NCT03957720   China
   The First Affiliated Hospital, Sun Yat-Sen University
      2022   Phase 1   ChiCTR2200058434   China
   Wilson Therapeutics AB
      2018   Phase 3   EUCTR2017-004135-36-HU   Austria;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004135-36-GB   Austria;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004135-36-FR   Austria;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004135-36-ES   Austria;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Spain;United Kingdom;United States
   gmp-orphan SA
      2017   Phase 3   EUCTR2016-003876-29-AT   Austria;Brazil;Denmark;France;Germany;Italy;Poland;United Kingdom
Plasma exchange
   Institute of Liver and Biliary Sciences, India
      2024   -   NCT06698991   India
SOC therapy
   Alexion Pharmaceuticals, Inc.
      2018   Phase 3   NCT03403205   Australia;Austria;Belgium;Canada;Czechia;Denmark;France;Germany;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;New Zealand;Poland;Russian Federation;Serbia;Singapore;Spain;Taiwan;Turkey;United Kingdom;United States
Standard medical treatment
   Institute of Liver and Biliary Sciences, India
      2024   -   NCT06698991   India
Standard OF care medications
   Alexion Pharmaceuticals
      2016   -   NCT02763215   Austria;Germany;Poland;United Kingdom;United States
Teta 4HCL
   Orphalan
      2019   Phase 3   EUCTR2016-003876-29-BE   Austria;Belgium;Brazil;Denmark;France;Germany;Italy;Poland;Sweden;United Kingdom;United States
      2018   Phase 3   NCT03539952   Belgium;Brazil;Denmark;France;Germany;Italy;Poland;Sweden;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003876-29-DK   Austria;Belgium;Brazil;Denmark;France;Germany;Italy;Poland;Sweden;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003876-29-DE   Austria;Belgium;Brazil;Denmark;France;Germany;Italy;Poland;Sweden;United Kingdom;United States
   gmp-orphan SA
      2017   Phase 3   EUCTR2016-003876-29-GB   Austria;Belgium;Brazil;Denmark;France;Germany;Italy;Poland;Sweden;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003876-29-AT   Austria;Brazil;Denmark;France;Germany;Italy;Poland;United Kingdom
Teta.4HCI
   GMP ORPHAN SA
      2017   Phase 3   EUCTR2016-003876-29-IT   Austria;Brazil;Denmark;France;Germany;Italy;Micronesia, Federated States of;Poland;United Kingdom;United States
Teta.4HCL
   gmp-orphan SA
      2017   Phase 3   EUCTR2016-003876-29-GB   Austria;Belgium;Brazil;Denmark;France;Germany;Italy;Poland;Sweden;United Kingdom;United States
Tetrathiomolybdate
   National Center for Research Resources (NCRR)
      1994   Phase 3   NCT00004339   United States
Tiomolibdic acid
   Alexion Pharmaceuticals, Inc
      2019   Phase 3   EUCTR2017-004135-36-DK   Australia;Austria;Belgium;Brazil;Canada;Colombia;Czech Republic;Czechia;Denmark;France;Germany;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004135-36-CZ   Australia;Austria;Belgium;Brazil;Canada;Colombia;Czech Republic;Czechia;Denmark;France;Germany;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
   Alexion Pharmaceuticals, Inc.
      2021   Phase 3   EUCTR2021-001015-82-ES   Australia;Austria;Canada;Czechia;Denmark;France;Germany;Hungary;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;Turkey;United Kingdom;United States
      2021   Phase 3   EUCTR2021-001015-82-DE   Australia;France;Germany;Japan;Korea, Republic of;Poland;Spain;United Kingdom
      -   Phase 3   EUCTR2021-001015-82-PL   Australia;Austria;Canada;Czechia;Denmark;France;Germany;Hungary;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;Turkey;United Kingdom;United States
Trientine
   Excelsior
      2018   -   NCT03299829   Taiwan
   National Center for Research Resources (NCRR)
      1994   Phase 3   NCT00004339   United States
Trientine dihydrochloride
   Alexion Pharmaceuticals Inc.
      2021   Phase 2   EUCTR2020-005832-31-DK   Denmark
   Alexion Pharmaceuticals, Inc
      2020   Phase 3   EUCTR2017-004135-36-PT   Australia;Austria;Belgium;Brazil;Canada;Colombia;Czech Republic;Denmark;France;Germany;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
      2020   Phase 3   EUCTR2017-004135-36-NL   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
      2019   Phase 3   EUCTR2017-004135-36-SE   Australia;Austria;Belgium;Brazil;Canada;Colombia;Czech Republic;Denmark;France;Germany;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
      2019   Phase 3   EUCTR2017-004135-36-DK   Australia;Austria;Belgium;Brazil;Canada;Colombia;Czech Republic;Czechia;Denmark;France;Germany;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004135-36-DE   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czechia;Denmark;France;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Democratic People's Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004135-36-AT   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Democratic People's Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
      -   Phase 3   EUCTR2017-004135-36-PL   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
      -   Phase 3   EUCTR2017-004135-36-BE   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
   Univar BV
      2016   Phase 4   NCT02426905   Germany;Greece;Italy;United Kingdom
      2013   Phase 1   NCT01874028   Germany
   Univar Solutions, B.V.
      2021   Phase 4   EUCTR2020-004604-33-PL   Denmark;France;Germany;Poland
      2021   Phase 4   EUCTR2020-004604-33-FR   Denmark;France;Germany;Poland
      2021   Phase 4   EUCTR2020-004604-33-DK   Denmark;France;Germany;Poland
      2021   Phase 4   EUCTR2020-004604-33-DE   Denmark;France;Germany;Poland
   Wilson Therapeutics AB
      2018   Phase 3   EUCTR2017-004135-36-HU   Austria;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004135-36-GB   Austria;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004135-36-FR   Austria;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004135-36-ES   Austria;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Spain;United Kingdom;United States
Trientine dihydrochloride 300MG capsules
   UNIVAR LTD
      2016   Phase 2   EUCTR2013-003564-31-IT   France;Germany;Greece;Italy;Spain;United Kingdom
   Univar B.V.
      2014   Phase 4   EUCTR2013-003564-31-DE   Germany;Italy
Trientine tetrahydrochloride
   GMP ORPHAN SA
      2017   Phase 3   EUCTR2016-003876-29-IT   Austria;Brazil;Denmark;France;Germany;Italy;Micronesia, Federated States of;Poland;United Kingdom;United States
   Orphalan
      2019   Phase 3   EUCTR2016-003876-29-BE   Austria;Belgium;Brazil;Denmark;France;Germany;Italy;Poland;Sweden;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003876-29-DK   Austria;Belgium;Brazil;Denmark;France;Germany;Italy;Poland;Sweden;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003876-29-DE   Austria;Belgium;Brazil;Denmark;France;Germany;Italy;Poland;Sweden;United Kingdom;United States
   gmp-orphan SA
      2017   Phase 3   EUCTR2016-003876-29-GB   Austria;Belgium;Brazil;Denmark;France;Germany;Italy;Poland;Sweden;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003876-29-AT   Austria;Brazil;Denmark;France;Germany;Italy;Poland;United Kingdom
Triethylenetetramine dihydrochloride
   Univar Solutions, B.V.
      2021   Phase 4   EUCTR2020-004604-33-PL   Denmark;France;Germany;Poland
      2021   Phase 4   EUCTR2020-004604-33-FR   Denmark;France;Germany;Poland
      2021   Phase 4   EUCTR2020-004604-33-DK   Denmark;France;Germany;Poland
      2021   Phase 4   EUCTR2020-004604-33-DE   Denmark;France;Germany;Poland
Ultrasound
   University of Aarhus
      2016   -   NCT02702765   Denmark
UX701
   Ultragenyx Pharmaceutical Inc
      2021   Phase 1/Phase 2   NCT04884815   Canada;Portugal;Spain;United Kingdom;United States
   Ultragenyx Pharmaceutical Inc.
      2023   Phase 1;Phase 2;Phase 3   EUCTR2020-005266-34-PT   Argentina;Austria;Brazil;Canada;France;Germany;Italy;Japan;Poland;Portugal;Spain;United Kingdom;United States
      2022   Phase 1;Phase 2;Phase 3   EUCTR2020-005266-34-ES   Argentina;Austria;Brazil;Canada;France;Germany;Italy;Japan;Poland;Portugal;Spain;United Kingdom;United States
VTX-801
   Vivet Therapeutics SAS
      2021   Phase 1/Phase 2   NCT04537377   Denmark;Germany;United Kingdom;United States
      2021   Phase 1;Phase 2   EUCTR2020-000963-22-DK   Denmark;Germany;United Kingdom;United States
      2021   Phase 1;Phase 2   EUCTR2020-000963-22-DE   Denmark;Germany;United Kingdom;United States
Wilzin
   Alexion Pharmaceuticals, Inc
      2019   Phase 3   EUCTR2017-004135-36-DK   Australia;Austria;Belgium;Brazil;Canada;Colombia;Czech Republic;Czechia;Denmark;France;Germany;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
   The Department of Hepatology and Gastroenterology, Aarhus University Hospital
      2019   Phase 4   EUCTR2019-000905-57-DK   Denmark
WTX101
   Alexion Pharmaceuticals, INC.
      2014   Phase 2   EUCTR2014-001703-41-DE   Austria;Germany;Poland;United Kingdom;United States
   Alexion Pharmaceuticals, Inc.
      2014   Phase 2   EUCTR2014-001703-41-AT   Austria;Germany;Poland;United Kingdom;United States
   Wilson Therapeutics AB
      2018   Phase 3   EUCTR2017-004135-36-HU   Austria;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004135-36-GB   Austria;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004135-36-FR   Austria;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004135-36-ES   Austria;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Spain;United Kingdom;United States
      2015   Phase 2   EUCTR2014-001703-41-GB   Austria;Germany;Poland;United Kingdom;United States
      2014   Phase 2   EUCTR2014-001703-41-PL   Austria;Germany;Poland;United Kingdom;United States
Zinc
   Prof. Elon Pras
      2018   -   NCT03659331   -
   The First Affiliated Hospital, Sun Yat-Sen University
      2022   Phase 1   ChiCTR2200058434   China
Zinc acetate
   National Center for Research Resources (NCRR)
      1993   Phase 4   NCT00004338   United States
   Nobelpharma
      2004   Phase 3   NCT00212368   -
   The Department of Hepatology and Gastroenterology, Aarhus University Hospital
      2019   Phase 4   EUCTR2019-000905-57-DK   Denmark
Zinc acetate dihydrate
   Alexion Pharmaceuticals, Inc
      2020   Phase 3   EUCTR2017-004135-36-PT   Australia;Austria;Belgium;Brazil;Canada;Colombia;Czech Republic;Denmark;France;Germany;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
      2020   Phase 3   EUCTR2017-004135-36-NL   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
      2019   Phase 3   EUCTR2017-004135-36-SE   Australia;Austria;Belgium;Brazil;Canada;Colombia;Czech Republic;Denmark;France;Germany;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
      2019   Phase 3   EUCTR2017-004135-36-DK   Australia;Austria;Belgium;Brazil;Canada;Colombia;Czech Republic;Czechia;Denmark;France;Germany;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004135-36-DE   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czechia;Denmark;France;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Democratic People's Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004135-36-CZ   Australia;Austria;Belgium;Brazil;Canada;Colombia;Czech Republic;Czechia;Denmark;France;Germany;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004135-36-AT   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Democratic People's Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
      -   Phase 3   EUCTR2017-004135-36-PL   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
      -   Phase 3   EUCTR2017-004135-36-BE   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Singapore;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
   Wilson Therapeutics AB
      2018   Phase 3   EUCTR2017-004135-36-HU   Austria;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004135-36-GB   Austria;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004135-36-FR   Austria;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004135-36-ES   Austria;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Spain;United Kingdom;United States
Zinc gluconate
   Second Affiliated Hospital, School of Medicine, Zhejiang University
      2019   Early Phase 1   NCT03957720   China
   The Department of Hepatology and Gastroenterology, Aarhus University Hospital
      2019   Phase 4   EUCTR2019-000905-57-DK   Denmark
   The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine
      2021   Phase 0   ChiCTR2100053629   China
Zink natur-drogeriet
   The Department of Hepatology and Gastroenterology, Aarhus University Hospital
      2019   Phase 4   EUCTR2019-000905-57-DK   Denmark